1Douglas Hospital Research Center and the Dept of Neurology, McGill University, Montréal, Québec, Canada.
Beta-amyloid peptide (Abeta) in Alzheimer's disease (AD) brain deposits inhibits cholinergic functions. This Abeta-induced hypoactivity may explain neuronal vulnerability and have broader physiological implications.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: